Edesa Biotech Inc (EDSA) Stock Price, Quote & News

Company Profile

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. It develops EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phase 3 clinical study to treat chronic aller...

Industry: Biotechnology

Sector: Healthcare

Phone: 289 800 9600

Website: www.edesabiotech.com

Address:

100 Spy Court, Markham, Canada

Sw1ngb0t Apr. 4 at 3:06 PM

$EDSA $11.68+ has been foretold... and that probably leads to more. let's get it!

0 · Reply

EireTrader Apr. 4 at 8:08 AM

$EDSA ... Shareholder letter for 2025 from Par 😇 has been filed also.

0 · Reply

mapleleafdave Apr. 3 at 11:37 PM

$EDSA Get to the reading. Lots of info filed today. https://www.edesabiotech.com/investors/sec-filings/

2 · Reply

Treb3k Apr. 3 at 10:23 PM

$EDSA omg

0 · Reply

VoxChameleon Apr. 3 at 4:46 PM

$EDSA Float is basically completely locked. Insiders own 20% not 10% like listed. Par himself owns 19.99% Impressive.

1 · Reply

RKLBupupup Apr. 3 at 3:43 AM

$EDSA Trump Administration Prepares Up To 100% Pharma Tariffs On Drugs From Companies That Have Not Struck A Deal Yet: Report Pharmaceutical companies can avoid these tariffs if they move their manufacturing to the U.S. or are currently negotiating a deal with the Trump administratThe report stated that there may be exemptions for drugs used to treat certain diseases. The Trump administration is reportedly preparing to impose tariffs of up to 100% on drugs from pharmaceutical companies that have not yet struck deals with the White House.

0 · Reply

Sw1ngb0t Apr. 2 at 8:16 PM

$SST $EDSA $AIFF $ANNA $PLYX

0 · Reply

jrml1957 Apr. 2 at 7:43 PM

$EDSA Trending to $6.50. Three positive postings in March, an esesa record!

0 · Reply

RKLBupupup Apr. 2 at 5:29 PM

$EDSA did Par buy more shares?

1 · Reply

Treb3k Apr. 2 at 3:48 PM

$EDSA par wouldnt have missed the photo op

0 · Reply

Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit

Mar 26, 2026, 9:15 AM EDT - 9 days ago

Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment

Feb 24, 2026, 9:15 AM EST - 5 weeks ago

Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study

Feb 13, 2026, 4:20 PM EST - 7 weeks ago

Edesa Biotech Reports Fiscal 1st Quarter 2026 Results

Dec 12, 2025, 4:20 PM EST - 4 months ago

Edesa Biotech Reports Fiscal Year 2025 Results

Oct 31, 2025, 4:30 PM EDT - 5 months ago

Edesa Biotech Announces Upcoming Conference Schedule

Oct 28, 2025, 7:45 AM EDT - 5 months ago

Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study

Aug 8, 2025, 4:35 PM EDT - 8 months ago

Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results

May 14, 2025, 4:15 PM EDT - 11 months ago

Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results

Apr 28, 2025, 4:30 PM EDT - 1 year ago

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference

Apr 4, 2025, 4:15 PM EDT - 1 year ago

Edesa Biotech Announces Chief Financial Officer Transition

Feb 14, 2025, 4:15 PM EST - 1 year ago

Edesa Biotech Reports Fiscal 1st Quarter 2025 Results

Feb 13, 2025, 7:00 AM EST - 1 year ago

Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Dec 13, 2024, 4:30 PM EST - 1 year ago

Edesa Biotech Reports Fiscal Year 2024 Results

Oct 31, 2024, 8:15 AM EDT - 1 year ago

Edesa Biotech's Founder Makes Strategic Investment in the Company

Sep 13, 2024, 7:38 PM EDT - 1 year ago

Pardeep Nijhawan Provides Update to Beneficial Ownership of Securities of Edesa Biotech, Inc.

Aug 9, 2024, 4:20 PM EDT - 1 year ago

Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results

Jun 24, 2024, 8:20 AM EDT - 1 year ago

BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS

May 10, 2024, 4:15 PM EDT - 2 years ago

Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results

Apr 2, 2024, 9:00 AM EDT - 2 years ago

Edesa Biotech to Participate in Upcoming Investor Conferences

Mar 21, 2024, 4:30 PM EDT - 2 years ago

Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference

Mar 7, 2024, 8:45 AM EST - 2 years ago

Edesa Biotech to Participate in Barclays Global Healthcare Conference

Mar 4, 2024, 4:30 PM EST - 2 years ago

Edesa Biotech to Participate in Upcoming Dermatology Meetings

Feb 9, 2024, 4:15 PM EST - 2 years ago

Edesa Biotech Reports Fiscal 1st Quarter 2024 Results

Jan 4, 2024, 4:15 PM EST - 2 years ago

Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week

Dec 15, 2023, 4:10 PM EST - 2 years ago

Edesa Biotech Reports Fiscal Year 2023 Results

Nov 20, 2023, 4:05 PM EST - 2 years ago

Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study

Oct 26, 2023, 4:05 PM EDT - 2 years ago

Edesa Biotech to Present at Dermatology Drug Development Summit

Oct 25, 2023, 9:10 AM EDT - 2 years ago

Regulators Approve Updated Phase 3 Trial Design for Edesa Biotech's ARDS Drug

Oct 12, 2023, 12:15 PM EDT - 2 years ago

Edesa Biotech Secures $10 Million Credit Facility with Company Founder

Oct 12, 2023, 12:10 PM EDT - 2 years ago

Edesa Biotech to Receive Up To C$23 Million in Funding from Federal Government

Oct 10, 2023, 9:00 AM EDT - 2 years ago

Edesa Biotech Announces One-for-Seven Reverse Share Split

Sep 28, 2023, 8:15 AM EDT - 2 years ago

Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate

Aug 9, 2023, 4:15 PM EDT - 2 years ago

Edesa Biotech Reports Fiscal Third Quarter 2023 Results

Jul 26, 2023, 9:00 AM EDT - 2 years ago

Edesa Biotech to Participate in Upcoming Canaccord Genuity Growth Conference

Jun 28, 2023, 7:55 AM EDT - 3 years ago

Edesa Biotech's ARDS Drug Inhibits Inflammation from Influenza and Other Pathogens

Jun 27, 2023, 8:15 AM EDT - 3 years ago

Edesa Biotech Appoints Biotech Deal Veteran to CFO Role

Jun 15, 2023, 8:00 AM EDT - 3 years ago

Edesa Biotech Anti-Inflammatory Drug Candidate Assigned Name

May 11, 2023, 4:30 PM EDT - 3 years ago

Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results

Apr 20, 2023, 8:30 AM EDT - 3 years ago

Edesa Biotech to Participate in Swiss Biotech Day

Apr 4, 2023, 8:45 AM EDT - 3 years ago

The WHO and USAN Adopt Generic Name for Edesa's ARDS Drug Candidate

Mar 23, 2023, 4:30 PM EDT - 3 years ago

Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Disease Conference

Mar 16, 2023, 4:10 PM EDT - 3 years ago

Edesa Biotech to Present Favorable Dermatitis Drug Results at American Academy of Dermatology Association Annual Meeting

Mar 15, 2023, 8:10 AM EDT - 3 years ago

Edesa Biotech and FDA Agree on Primary Endpoint for Phase 3 ARDS Drug Study

Feb 10, 2023, 9:00 AM EST - 3 years ago

Edesa Biotech Reports Fiscal 1st Quarter 2023 Results

Feb 1, 2023, 8:15 AM EST - 3 years ago

Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study

Jan 17, 2023, 8:30 AM EST - 3 years ago

Edesa Biotech Reports Topline Phase 2b Results for Dermatology Drug

Dec 20, 2022, 8:30 AM EST - 3 years ago

FDA Grants Fast Track to Edesa Biotech's ARDS Drug Candidate

Dec 16, 2022, 9:00 AM EST - 3 years ago

Edesa Biotech Reports Fiscal Year 2022 Results

Dec 2, 2022, 8:00 AM EST - 3 years ago

Edesa Biotech to Participate in the 2022 Cantor Fitzgerald Dermatology Conference

Sw1ngb0t Apr. 4 at 3:06 PM

$EDSA $11.68+ has been foretold... and that probably leads to more. let's get it!

0 · Reply

EireTrader Apr. 4 at 8:08 AM

$EDSA ... Shareholder letter for 2025 from Par 😇 has been filed also.

0 · Reply

mapleleafdave Apr. 3 at 11:37 PM

$EDSA Get to the reading. Lots of info filed today. https://www.edesabiotech.com/investors/sec-filings/

2 · Reply

Treb3k Apr. 3 at 10:23 PM

$EDSA omg

0 · Reply

VoxChameleon Apr. 3 at 4:46 PM

$EDSA Float is basically completely locked. Insiders own 20% not 10% like listed. Par himself owns 19.99% Impressive.

1 · Reply

RKLBupupup Apr. 3 at 3:43 AM

0 · Reply

Sw1ngb0t Apr. 2 at 8:16 PM

$SST $EDSA $AIFF $ANNA $PLYX

0 · Reply

jrml1957 Apr. 2 at 7:43 PM

$EDSA Trending to $6.50. Three positive postings in March, an esesa record!

0 · Reply

RKLBupupup Apr. 2 at 5:29 PM

$EDSA did Par buy more shares?

1 · Reply

Treb3k Apr. 2 at 3:48 PM

$EDSA par wouldnt have missed the photo op

0 · Reply

Treb3k Apr. 2 at 3:48 PM

$EDSA halt it for the announcement!

0 · Reply

Moneyybaggs Apr. 2 at 3:00 PM

$EDSA Maybe it’s a manufacturing PR for EB05. One can certainly dream!!!

1 · Reply

Moneyybaggs Apr. 2 at 2:42 PM

$EDSA Announcement from who ET?

1 · Reply

Sw1ngb0t Apr. 2 at 2:33 PM

$EDSA chart science wins again! thank you for your value creating service, shorts... I hope you felt included

0 · Reply

EireTrader Apr. 2 at 2:29 PM

$EDSA ... Big Biomanufacturing Annoucement today...probably not us...yet

0 · Reply

Moneyybaggs Apr. 2 at 2:27 PM

$EDSA UP, UP AND AWAY IN OUR BEAUTIFUL TURDESA BALLOON!!! Love how this is trading!!!

0 · Reply

WelshDragon75 Apr. 2 at 2:15 PM

$EDSA nice moves

0 · Reply

VoxChameleon Apr. 2 at 1:34 PM

$EDSA

0 · Reply

IjustTradeiT Apr. 2 at 1:13 PM

$EDSA Green in a sea of red

0 · Reply

WienersOut4RCAT Apr. 2 at 2:59 AM

$EDSA jenf

0 · Reply

EdV3 Apr. 2 at 2:15 AM

$EDSA https://x.com/acyn/status/2039400041790783785?s=46 They finally did it. They actually sent Gary to space. 🙏🙏🙏🙏🙏 I had been calling for this day for many years

0 · Reply

pedalpedal Apr. 1 at 10:58 PM

$EDSA ??? time will tell

0 · Reply

Market Cap	51.26M
Revenue (ttm)	0.00
Net Income (ttm)	-7.19M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	418,000
Avg Vol	5,325,728
Day's Range	N/A - N/A
Shares Out	8.35M
Stochastic %K	36%
Beta	-0.68
Analysts	Strong Sell
Price Target	$11.00